Enoxaparin Prevents Steroid-Related Avascular Necrosis of the Femoral Head

Nontraumatic osteonecrosis of the femoral head is still a challenging problem in orthopedic surgery. It is responsible for 10% of the 500,000 hip replacement surgeries in the USA and affects relatively young, active patients in particular. Main reasons for nontraumatic osteonecrosis are glucocortico...

Full description

Bibliographic Details
Main Authors: Beckmann, Rainer, Shaheen, Hayfaa, Kweider, Nisreen, Ghassemi, Alireza, Fragoulis, Athanassios, Hermanns-Sachweh, Benita, Pufe, Thomas, Kadyrov, Mamed, Drescher, Wolf
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106066/
id pubmed-4106066
recordtype oai_dc
spelling pubmed-41060662014-08-10 Enoxaparin Prevents Steroid-Related Avascular Necrosis of the Femoral Head Beckmann, Rainer Shaheen, Hayfaa Kweider, Nisreen Ghassemi, Alireza Fragoulis, Athanassios Hermanns-Sachweh, Benita Pufe, Thomas Kadyrov, Mamed Drescher, Wolf Research Article Nontraumatic osteonecrosis of the femoral head is still a challenging problem in orthopedic surgery. It is responsible for 10% of the 500,000 hip replacement surgeries in the USA and affects relatively young, active patients in particular. Main reasons for nontraumatic osteonecrosis are glucocorticoid use, alcoholism, thrombophilia, and hypofibrinolysis (Glueck et al., 1997; Orth and Anagnostakos, 2013). One pathomechanism of steroid-induced osteonecrosis is thought to be impaired blood flow to the femoral head caused by increased thrombus formation and vasoconstriction. To investigate the preventive effect of enoxaparin on steroid-related osteonecrosis, we used male New Zealand white rabbits. Osteonecrosis was induced by methylprednisolone-injection (1 × 20 mg/kg body weight). Control animals were treated with phosphate-buffered saline. Treatment consisted of an injection of 11.7 mg/kg body weight of enoxaparin per day (Clexane) in addition to methylprednisolone. Four weeks after methylprednisolone-injection the animals were sacrificed. Histology (hematoxylin-eosin and Ladewig staining) was performed, and empty lacunae and histological signs of osteonecrosis were quantified. Histomorphometry revealed a significant increase in empty lacunae and necrotic changed osteocytes in glucocorticoid-treated animals as compared with the glucocorticoid- and Clexane-treated animals and with the control group. No significant difference was detected between the glucocorticoid and Clexane group and the control group. This finding suggests that cotreatment with enoxaparin has the potential to prevent steroid-associated osteonecrosis. Hindawi Publishing Corporation 2014 2014-07-02 /pmc/articles/PMC4106066/ /pubmed/25110730 http://dx.doi.org/10.1155/2014/347813 Text en Copyright © 2014 Rainer Beckmann et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Beckmann, Rainer
Shaheen, Hayfaa
Kweider, Nisreen
Ghassemi, Alireza
Fragoulis, Athanassios
Hermanns-Sachweh, Benita
Pufe, Thomas
Kadyrov, Mamed
Drescher, Wolf
spellingShingle Beckmann, Rainer
Shaheen, Hayfaa
Kweider, Nisreen
Ghassemi, Alireza
Fragoulis, Athanassios
Hermanns-Sachweh, Benita
Pufe, Thomas
Kadyrov, Mamed
Drescher, Wolf
Enoxaparin Prevents Steroid-Related Avascular Necrosis of the Femoral Head
author_facet Beckmann, Rainer
Shaheen, Hayfaa
Kweider, Nisreen
Ghassemi, Alireza
Fragoulis, Athanassios
Hermanns-Sachweh, Benita
Pufe, Thomas
Kadyrov, Mamed
Drescher, Wolf
author_sort Beckmann, Rainer
title Enoxaparin Prevents Steroid-Related Avascular Necrosis of the Femoral Head
title_short Enoxaparin Prevents Steroid-Related Avascular Necrosis of the Femoral Head
title_full Enoxaparin Prevents Steroid-Related Avascular Necrosis of the Femoral Head
title_fullStr Enoxaparin Prevents Steroid-Related Avascular Necrosis of the Femoral Head
title_full_unstemmed Enoxaparin Prevents Steroid-Related Avascular Necrosis of the Femoral Head
title_sort enoxaparin prevents steroid-related avascular necrosis of the femoral head
description Nontraumatic osteonecrosis of the femoral head is still a challenging problem in orthopedic surgery. It is responsible for 10% of the 500,000 hip replacement surgeries in the USA and affects relatively young, active patients in particular. Main reasons for nontraumatic osteonecrosis are glucocorticoid use, alcoholism, thrombophilia, and hypofibrinolysis (Glueck et al., 1997; Orth and Anagnostakos, 2013). One pathomechanism of steroid-induced osteonecrosis is thought to be impaired blood flow to the femoral head caused by increased thrombus formation and vasoconstriction. To investigate the preventive effect of enoxaparin on steroid-related osteonecrosis, we used male New Zealand white rabbits. Osteonecrosis was induced by methylprednisolone-injection (1 × 20 mg/kg body weight). Control animals were treated with phosphate-buffered saline. Treatment consisted of an injection of 11.7 mg/kg body weight of enoxaparin per day (Clexane) in addition to methylprednisolone. Four weeks after methylprednisolone-injection the animals were sacrificed. Histology (hematoxylin-eosin and Ladewig staining) was performed, and empty lacunae and histological signs of osteonecrosis were quantified. Histomorphometry revealed a significant increase in empty lacunae and necrotic changed osteocytes in glucocorticoid-treated animals as compared with the glucocorticoid- and Clexane-treated animals and with the control group. No significant difference was detected between the glucocorticoid and Clexane group and the control group. This finding suggests that cotreatment with enoxaparin has the potential to prevent steroid-associated osteonecrosis.
publisher Hindawi Publishing Corporation
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106066/
_version_ 1613116461656571904